Global Antiviral Face Masks Market Research Report 2023
SKU ID : QYR-23477865 | Publishing Date : 11-Apr-2023
Detailed TOC of Global Antiviral Face Masks Market Research Report 2023
1 Antiviral Face Masks Market Overview1.1 Product Overview and Scope of Antiviral Face Masks
1.2 Antiviral Face Masks Segment by Type
1.2.1 Global Antiviral Face Masks Market Value Comparison by Type (2023-2029)
1.2.2 Flat-fold Type
1.2.3 Cup Style
1.3 Antiviral Face Masks Segment by Application
1.3.1 Global Antiviral Face Masks Market Value by Application: (2023-2029)
1.3.2 Healthcare Workers
1.3.3 General Public
1.4 Global Antiviral Face Masks Market Size Estimates and Forecasts
1.4.1 Global Antiviral Face Masks Revenue 2018-2029
1.4.2 Global Antiviral Face Masks Sales 2018-2029
1.4.3 Global Antiviral Face Masks Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Antiviral Face Masks Market Competition by Manufacturers
2.1 Global Antiviral Face Masks Sales Market Share by Manufacturers (2018-2023)
2.2 Global Antiviral Face Masks Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Antiviral Face Masks Average Price by Manufacturers (2018-2023)
2.4 Global Antiviral Face Masks Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Antiviral Face Masks, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antiviral Face Masks, Product Type & Application
2.7 Antiviral Face Masks Market Competitive Situation and Trends
2.7.1 Antiviral Face Masks Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antiviral Face Masks Players Market Share by Revenue
2.7.3 Global Antiviral Face Masks Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antiviral Face Masks Retrospective Market Scenario by Region
3.1 Global Antiviral Face Masks Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Antiviral Face Masks Global Antiviral Face Masks Sales by Region: 2018-2029
3.2.1 Global Antiviral Face Masks Sales by Region: 2018-2023
3.2.2 Global Antiviral Face Masks Sales by Region: 2024-2029
3.3 Global Antiviral Face Masks Global Antiviral Face Masks Revenue by Region: 2018-2029
3.3.1 Global Antiviral Face Masks Revenue by Region: 2018-2023
3.3.2 Global Antiviral Face Masks Revenue by Region: 2024-2029
3.4 North America Antiviral Face Masks Market Facts & Figures by Country
3.4.1 North America Antiviral Face Masks Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Antiviral Face Masks Sales by Country (2018-2029)
3.4.3 North America Antiviral Face Masks Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antiviral Face Masks Market Facts & Figures by Country
3.5.1 Europe Antiviral Face Masks Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Antiviral Face Masks Sales by Country (2018-2029)
3.5.3 Europe Antiviral Face Masks Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antiviral Face Masks Market Facts & Figures by Country
3.6.1 Asia Pacific Antiviral Face Masks Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Antiviral Face Masks Sales by Country (2018-2029)
3.6.3 Asia Pacific Antiviral Face Masks Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antiviral Face Masks Market Facts & Figures by Country
3.7.1 Latin America Antiviral Face Masks Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Antiviral Face Masks Sales by Country (2018-2029)
3.7.3 Latin America Antiviral Face Masks Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antiviral Face Masks Market Facts & Figures by Country
3.8.1 Middle East and Africa Antiviral Face Masks Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Antiviral Face Masks Sales by Country (2018-2029)
3.8.3 Middle East and Africa Antiviral Face Masks Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antiviral Face Masks Sales by Type (2018-2029)
4.1.1 Global Antiviral Face Masks Sales by Type (2018-2023)
4.1.2 Global Antiviral Face Masks Sales by Type (2024-2029)
4.1.3 Global Antiviral Face Masks Sales Market Share by Type (2018-2029)
4.2 Global Antiviral Face Masks Revenue by Type (2018-2029)
4.2.1 Global Antiviral Face Masks Revenue by Type (2018-2023)
4.2.2 Global Antiviral Face Masks Revenue by Type (2024-2029)
4.2.3 Global Antiviral Face Masks Revenue Market Share by Type (2018-2029)
4.3 Global Antiviral Face Masks Price by Type (2018-2029)
5 Segment by Application
5.1 Global Antiviral Face Masks Sales by Application (2018-2029)
5.1.1 Global Antiviral Face Masks Sales by Application (2018-2023)
5.1.2 Global Antiviral Face Masks Sales by Application (2024-2029)
5.1.3 Global Antiviral Face Masks Sales Market Share by Application (2018-2029)
5.2 Global Antiviral Face Masks Revenue by Application (2018-2029)
5.2.1 Global Antiviral Face Masks Revenue by Application (2018-2023)
5.2.2 Global Antiviral Face Masks Revenue by Application (2024-2029)
5.2.3 Global Antiviral Face Masks Revenue Market Share by Application (2018-2029)
5.3 Global Antiviral Face Masks Price by Application (2018-2029)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Corporation Information
6.1.2 3M Description and Business Overview
6.1.3 3M Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.1.4 3M Antiviral Face Masks Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Honeywell
6.2.1 Honeywell Corporation Information
6.2.2 Honeywell Description and Business Overview
6.2.3 Honeywell Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Honeywell Antiviral Face Masks Product Portfolio
6.2.5 Honeywell Recent Developments/Updates
6.3 Unicharm
6.3.1 Unicharm Corporation Information
6.3.2 Unicharm Description and Business Overview
6.3.3 Unicharm Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Unicharm Antiviral Face Masks Product Portfolio
6.3.5 Unicharm Recent Developments/Updates
6.4 Kimberly-clark
6.4.1 Kimberly-clark Corporation Information
6.4.2 Kimberly-clark Description and Business Overview
6.4.3 Kimberly-clark Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kimberly-clark Antiviral Face Masks Product Portfolio
6.4.5 Kimberly-clark Recent Developments/Updates
6.5 KOWA
6.5.1 KOWA Corporation Information
6.5.2 KOWA Description and Business Overview
6.5.3 KOWA Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.5.4 KOWA Antiviral Face Masks Product Portfolio
6.5.5 KOWA Recent Developments/Updates
6.6 UVEX
6.6.1 UVEX Corporation Information
6.6.2 UVEX Description and Business Overview
6.6.3 UVEX Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.6.4 UVEX Antiviral Face Masks Product Portfolio
6.6.5 UVEX Recent Developments/Updates
6.7 CM
6.6.1 CM Corporation Information
6.6.2 CM Description and Business Overview
6.6.3 CM Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CM Antiviral Face Masks Product Portfolio
6.7.5 CM Recent Developments/Updates
6.8 Te Yin
6.8.1 Te Yin Corporation Information
6.8.2 Te Yin Description and Business Overview
6.8.3 Te Yin Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Te Yin Antiviral Face Masks Product Portfolio
6.8.5 Te Yin Recent Developments/Updates
6.9 Japan Vilene Company
6.9.1 Japan Vilene Company Corporation Information
6.9.2 Japan Vilene Company Description and Business Overview
6.9.3 Japan Vilene Company Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Japan Vilene Company Antiviral Face Masks Product Portfolio
6.9.5 Japan Vilene Company Recent Developments/Updates
6.10 Shanghai Dasheng
6.10.1 Shanghai Dasheng Corporation Information
6.10.2 Shanghai Dasheng Description and Business Overview
6.10.3 Shanghai Dasheng Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Shanghai Dasheng Antiviral Face Masks Product Portfolio
6.10.5 Shanghai Dasheng Recent Developments/Updates
6.11 Winner Medical
6.11.1 Winner Medical Corporation Information
6.11.2 Winner Medical Antiviral Face Masks Description and Business Overview
6.11.3 Winner Medical Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Winner Medical Antiviral Face Masks Product Portfolio
6.11.5 Winner Medical Recent Developments/Updates
6.12 Suzhou Sanical
6.12.1 Suzhou Sanical Corporation Information
6.12.2 Suzhou Sanical Antiviral Face Masks Description and Business Overview
6.12.3 Suzhou Sanical Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Suzhou Sanical Antiviral Face Masks Product Portfolio
6.12.5 Suzhou Sanical Recent Developments/Updates
6.13 BDS
6.13.1 BDS Corporation Information
6.13.2 BDS Antiviral Face Masks Description and Business Overview
6.13.3 BDS Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.13.4 BDS Antiviral Face Masks Product Portfolio
6.13.5 BDS Recent Developments/Updates
6.14 Sinotextiles
6.14.1 Sinotextiles Corporation Information
6.14.2 Sinotextiles Antiviral Face Masks Description and Business Overview
6.14.3 Sinotextiles Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Sinotextiles Antiviral Face Masks Product Portfolio
6.14.5 Sinotextiles Recent Developments/Updates
6.15 Irema
6.15.1 Irema Corporation Information
6.15.2 Irema Antiviral Face Masks Description and Business Overview
6.15.3 Irema Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Irema Antiviral Face Masks Product Portfolio
6.15.5 Irema Recent Developments/Updates
6.16 DACH Schutzbekleidung
6.16.1 DACH Schutzbekleidung Corporation Information
6.16.2 DACH Schutzbekleidung Antiviral Face Masks Description and Business Overview
6.16.3 DACH Schutzbekleidung Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.16.4 DACH Schutzbekleidung Antiviral Face Masks Product Portfolio
6.16.5 DACH Schutzbekleidung Recent Developments/Updates
6.17 Tamagawa Eizai
6.17.1 Tamagawa Eizai Corporation Information
6.17.2 Tamagawa Eizai Antiviral Face Masks Description and Business Overview
6.17.3 Tamagawa Eizai Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Tamagawa Eizai Antiviral Face Masks Product Portfolio
6.17.5 Tamagawa Eizai Recent Developments/Updates
6.18 KOBAYASHI Pharmaceutical
6.18.1 KOBAYASHI Pharmaceutical Corporation Information
6.18.2 KOBAYASHI Pharmaceutical Antiviral Face Masks Description and Business Overview
6.18.3 KOBAYASHI Pharmaceutical Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.18.4 KOBAYASHI Pharmaceutical Antiviral Face Masks Product Portfolio
6.18.5 KOBAYASHI Pharmaceutical Recent Developments/Updates
6.19 CardinalHealth
6.19.1 CardinalHealth Corporation Information
6.19.2 CardinalHealth Antiviral Face Masks Description and Business Overview
6.19.3 CardinalHealth Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.19.4 CardinalHealth Antiviral Face Masks Product Portfolio
6.19.5 CardinalHealth Recent Developments/Updates
6.20 Essity (BSN Medical)
6.20.1 Essity (BSN Medical) Corporation Information
6.20.2 Essity (BSN Medical) Antiviral Face Masks Description and Business Overview
6.20.3 Essity (BSN Medical) Antiviral Face Masks Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Essity (BSN Medical) Antiviral Face Masks Product Portfolio
6.20.5 Essity (BSN Medical) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antiviral Face Masks Industry Chain Analysis
7.2 Antiviral Face Masks Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antiviral Face Masks Production Mode & Process
7.4 Antiviral Face Masks Sales and Marketing
7.4.1 Antiviral Face Masks Sales Channels
7.4.2 Antiviral Face Masks Distributors
7.5 Antiviral Face Masks Customers
8 Antiviral Face Masks Market Dynamics
8.1 Antiviral Face Masks Industry Trends
8.2 Antiviral Face Masks Market Drivers
8.3 Antiviral Face Masks Market Challenges
8.4 Antiviral Face Masks Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Figures, Tables and Charts Available in Global Antiviral Face Masks Market Research Report 2023
List of TablesTable 1. Global Antiviral Face Masks Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Antiviral Face Masks Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Antiviral Face Masks Market Competitive Situation by Manufacturers in 2022
Table 4. Global Antiviral Face Masks Sales (M Units) of Key Manufacturers (2018-2023)
Table 5. Global Antiviral Face Masks Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Antiviral Face Masks Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Antiviral Face Masks Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Antiviral Face Masks Average Price (US$/K Units) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Antiviral Face Masks, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Antiviral Face Masks, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antiviral Face Masks, Product Type & Application
Table 12. Global Key Manufacturers of Antiviral Face Masks, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antiviral Face Masks by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Face Masks as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antiviral Face Masks Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Antiviral Face Masks Sales by Region (2018-2023) & (M Units)
Table 18. Global Antiviral Face Masks Sales Market Share by Region (2018-2023)
Table 19. Global Antiviral Face Masks Sales by Region (2024-2029) & (M Units)
Table 20. Global Antiviral Face Masks Sales Market Share by Region (2024-2029)
Table 21. Global Antiviral Face Masks Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Antiviral Face Masks Revenue Market Share by Region (2018-2023)
Table 23. Global Antiviral Face Masks Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Antiviral Face Masks Revenue Market Share by Region (2024-2029)
Table 25. North America Antiviral Face Masks Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Antiviral Face Masks Sales by Country (2018-2023) & (M Units)
Table 27. North America Antiviral Face Masks Sales by Country (2024-2029) & (M Units)
Table 28. North America Antiviral Face Masks Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Antiviral Face Masks Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Antiviral Face Masks Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Antiviral Face Masks Sales by Country (2018-2023) & (M Units)
Table 32. Europe Antiviral Face Masks Sales by Country (2024-2029) & (M Units)
Table 33. Europe Antiviral Face Masks Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Antiviral Face Masks Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Antiviral Face Masks Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Antiviral Face Masks Sales by Region (2018-2023) & (M Units)
Table 37. Asia Pacific Antiviral Face Masks Sales by Region (2024-2029) & (M Units)
Table 38. Asia Pacific Antiviral Face Masks Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Antiviral Face Masks Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Antiviral Face Masks Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Antiviral Face Masks Sales by Country (2018-2023) & (M Units)
Table 42. Latin America Antiviral Face Masks Sales by Country (2024-2029) & (M Units)
Table 43. Latin America Antiviral Face Masks Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Antiviral Face Masks Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Antiviral Face Masks Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Antiviral Face Masks Sales by Country (2018-2023) & (M Units)
Table 47. Middle East & Africa Antiviral Face Masks Sales by Country (2024-2029) & (M Units)
Table 48. Middle East & Africa Antiviral Face Masks Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Antiviral Face Masks Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Antiviral Face Masks Sales (M Units) by Type (2018-2023)
Table 51. Global Antiviral Face Masks Sales (M Units) by Type (2024-2029)
Table 52. Global Antiviral Face Masks Sales Market Share by Type (2018-2023)
Table 53. Global Antiviral Face Masks Sales Market Share by Type (2024-2029)
Table 54. Global Antiviral Face Masks Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Antiviral Face Masks Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Antiviral Face Masks Revenue Market Share by Type (2018-2023)
Table 57. Global Antiviral Face Masks Revenue Market Share by Type (2024-2029)
Table 58. Global Antiviral Face Masks Price (US$/K Units) by Type (2018-2023)
Table 59. Global Antiviral Face Masks Price (US$/K Units) by Type (2024-2029)
Table 60. Global Antiviral Face Masks Sales (M Units) by Application (2018-2023)
Table 61. Global Antiviral Face Masks Sales (M Units) by Application (2024-2029)
Table 62. Global Antiviral Face Masks Sales Market Share by Application (2018-2023)
Table 63. Global Antiviral Face Masks Sales Market Share by Application (2024-2029)
Table 64. Global Antiviral Face Masks Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Antiviral Face Masks Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Antiviral Face Masks Revenue Market Share by Application (2018-2023)
Table 67. Global Antiviral Face Masks Revenue Market Share by Application (2024-2029)
Table 68. Global Antiviral Face Masks Price (US$/K Units) by Application (2018-2023)
Table 69. Global Antiviral Face Masks Price (US$/K Units) by Application (2024-2029)
Table 70. 3M Corporation Information
Table 71. 3M Description and Business Overview
Table 72. 3M Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 73. 3M Antiviral Face Masks Product
Table 74. 3M Recent Developments/Updates
Table 75. Honeywell Corporation Information
Table 76. Honeywell Description and Business Overview
Table 77. Honeywell Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 78. Honeywell Antiviral Face Masks Product
Table 79. Honeywell Recent Developments/Updates
Table 80. Unicharm Corporation Information
Table 81. Unicharm Description and Business Overview
Table 82. Unicharm Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 83. Unicharm Antiviral Face Masks Product
Table 84. Unicharm Recent Developments/Updates
Table 85. Kimberly-clark Corporation Information
Table 86. Kimberly-clark Description and Business Overview
Table 87. Kimberly-clark Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 88. Kimberly-clark Antiviral Face Masks Product
Table 89. Kimberly-clark Recent Developments/Updates
Table 90. KOWA Corporation Information
Table 91. KOWA Description and Business Overview
Table 92. KOWA Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 93. KOWA Antiviral Face Masks Product
Table 94. KOWA Recent Developments/Updates
Table 95. UVEX Corporation Information
Table 96. UVEX Description and Business Overview
Table 97. UVEX Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 98. UVEX Antiviral Face Masks Product
Table 99. UVEX Recent Developments/Updates
Table 100. CM Corporation Information
Table 101. CM Description and Business Overview
Table 102. CM Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 103. CM Antiviral Face Masks Product
Table 104. CM Recent Developments/Updates
Table 105. Te Yin Corporation Information
Table 106. Te Yin Description and Business Overview
Table 107. Te Yin Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 108. Te Yin Antiviral Face Masks Product
Table 109. Te Yin Recent Developments/Updates
Table 110. Japan Vilene Company Corporation Information
Table 111. Japan Vilene Company Description and Business Overview
Table 112. Japan Vilene Company Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 113. Japan Vilene Company Antiviral Face Masks Product
Table 114. Japan Vilene Company Recent Developments/Updates
Table 115. Shanghai Dasheng Corporation Information
Table 116. Shanghai Dasheng Description and Business Overview
Table 117. Shanghai Dasheng Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 118. Shanghai Dasheng Antiviral Face Masks Product
Table 119. Shanghai Dasheng Recent Developments/Updates
Table 120. Winner Medical Corporation Information
Table 121. Winner Medical Description and Business Overview
Table 122. Winner Medical Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 123. Winner Medical Antiviral Face Masks Product
Table 124. Winner Medical Recent Developments/Updates
Table 125. Suzhou Sanical Corporation Information
Table 126. Suzhou Sanical Description and Business Overview
Table 127. Suzhou Sanical Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 128. Suzhou Sanical Antiviral Face Masks Product
Table 129. Suzhou Sanical Recent Developments/Updates
Table 130. BDS Corporation Information
Table 131. BDS Description and Business Overview
Table 132. BDS Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 133. BDS Antiviral Face Masks Product
Table 134. BDS Recent Developments/Updates
Table 135. Sinotextiles Corporation Information
Table 136. Sinotextiles Description and Business Overview
Table 137. Sinotextiles Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 138. Sinotextiles Antiviral Face Masks Product
Table 139. Sinotextiles Recent Developments/Updates
Table 140. Irema Corporation Information
Table 141. Irema Description and Business Overview
Table 142. Irema Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 143. Irema Antiviral Face Masks Product
Table 144. Irema Recent Developments/Updates
Table 145. DACH Schutzbekleidung Corporation Information
Table 146. DACH Schutzbekleidung Description and Business Overview
Table 147. DACH Schutzbekleidung Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 148. DACH Schutzbekleidung Antiviral Face Masks Product
Table 149. DACH Schutzbekleidung Recent Developments/Updates
Table 150. Tamagawa Eizai Corporation Information
Table 151. Tamagawa Eizai Description and Business Overview
Table 152. Tamagawa Eizai Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 153. Tamagawa Eizai Antiviral Face Masks Product
Table 154. Tamagawa Eizai Recent Developments/Updates
Table 155. KOBAYASHI Pharmaceutical Corporation Information
Table 156. KOBAYASHI Pharmaceutical Description and Business Overview
Table 157. KOBAYASHI Pharmaceutical Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 158. KOBAYASHI Pharmaceutical Antiviral Face Masks Product
Table 159. KOBAYASHI Pharmaceutical Recent Developments/Updates
Table 160. CardinalHealth Corporation Information
Table 161. CardinalHealth Description and Business Overview
Table 162. CardinalHealth Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 163. CardinalHealth Antiviral Face Masks Product
Table 164. CardinalHealth Recent Developments/Updates
Table 165. Essity (BSN Medical) Corporation Information
Table 166. Essity (BSN Medical) Description and Business Overview
Table 167. Essity (BSN Medical) Antiviral Face Masks Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 168. Essity (BSN Medical) Antiviral Face Masks Product
Table 169. Essity (BSN Medical) Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Antiviral Face Masks Distributors List
Table 173. Antiviral Face Masks Customers List
Table 174. Antiviral Face Masks Market Trends
Table 175. Antiviral Face Masks Market Drivers
Table 176. Antiviral Face Masks Market Challenges
Table 177. Antiviral Face Masks Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antiviral Face Masks
Figure 2. Global Antiviral Face Masks Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Antiviral Face Masks Market Share by Type in 2022 & 2029
Figure 4. Flat-fold Type Product Picture
Figure 5. Cup Style Product Picture
Figure 6. Global Antiviral Face Masks Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Antiviral Face Masks Market Share by Application in 2022 & 2029
Figure 8. Healthcare Workers
Figure 9. General Public
Figure 10. Global Antiviral Face Masks Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Antiviral Face Masks Market Size (2018-2029) & (US$ Million)
Figure 12. Global Antiviral Face Masks Sales (2018-2029) & (M Units)
Figure 13. Global Antiviral Face Masks Average Price (US$/K Units) & (2018-2029)
Figure 14. Antiviral Face Masks Report Years Considered
Figure 15. Antiviral Face Masks Sales Share by Manufacturers in 2022
Figure 16. Global Antiviral Face Masks Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Antiviral Face Masks Players: Market Share by Revenue in 2022
Figure 18. Antiviral Face Masks Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Antiviral Face Masks Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Antiviral Face Masks Sales Market Share by Country (2018-2029)
Figure 21. North America Antiviral Face Masks Revenue Market Share by Country (2018-2029)
Figure 22. U.S. Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Antiviral Face Masks Sales Market Share by Country (2018-2029)
Figure 25. Europe Antiviral Face Masks Revenue Market Share by Country (2018-2029)
Figure 26. Germany Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Antiviral Face Masks Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Antiviral Face Masks Revenue Market Share by Region (2018-2029)
Figure 33. China Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Taiwan Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Philippines Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Antiviral Face Masks Sales Market Share by Country (2018-2029)
Figure 44. Latin America Antiviral Face Masks Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Antiviral Face Masks Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Antiviral Face Masks Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Antiviral Face Masks Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Antiviral Face Masks by Type (2018-2029)
Figure 54. Global Revenue Market Share of Antiviral Face Masks by Type (2018-2029)
Figure 55. Global Antiviral Face Masks Price (US$/K Units) by Type (2018-2029)
Figure 56. Global Sales Market Share of Antiviral Face Masks by Application (2018-2029)
Figure 57. Global Revenue Market Share of Antiviral Face Masks by Application (2018-2029)
Figure 58. Global Antiviral Face Masks Price (US$/K Units) by Application (2018-2029)
Figure 59. Antiviral Face Masks Value Chain
Figure 60. Antiviral Face Masks Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Keyplayers in Global Antiviral Face Masks Market Research Report 2023
3MHoneywell
Unicharm
Kimberly-clark
KOWA
UVEX
CM
Te Yin
Japan Vilene Company
Shanghai Dasheng
Winner Medical
Suzhou Sanical
BDS
Sinotextiles
Irema
DACH Schutzbekleidung
Tamagawa Eizai
KOBAYASHI Pharmaceutical
CardinalHealth
Essity (BSN Medical)